Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tyroserleutide (YSL), a small molecular tripeptide isolated from porcine spleen degradation products, inhibits the growth and metastasis of human hepatocellular carcinoma (HCC) both in vitro and in vivo.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 126 € | In Stock | |
2 mg | 187 € | In Stock | |
5 mg | 283 € | In Stock | |
10 mg | 430 € | In Stock | |
25 mg | 709 € | In Stock | |
50 mg | 997 € | In Stock | |
100 mg | 1.349 € | In Stock |
Description | Tyroserleutide (YSL), a small molecular tripeptide isolated from porcine spleen degradation products, inhibits the growth and metastasis of human hepatocellular carcinoma (HCC) both in vitro and in vivo. |
In vitro | Tyroserleutide (YSL) exhibits immunomodulatory properties, notably enhancing concanavalin (ConA) induced proliferation of mouse spleen lymphocytes, augmenting phagocytosis in mouse peritoneal macrophages, and boosting natural killer (NK) cell activity[1]. Additionally, as an immunotherapeutic tripeptide, YSL promotes apoptosis in hepatocarcinoma cells (H22) by downregulating Bcl-2 and cyclin D1 expression[2], establishing it as an effective agent for liver tumor cell apoptosis induction[2]. Moreover, YSL effectively inhibits tumor growth and cell migration without causing significant toxicities in major organs[2]. |
Molecular Weight | 381.42 |
Formula | C18H27N3O6 |
Cas No. | 138168-48-6 |
Smiles | C([C@@H](C(N[C@H](C(N[C@@H](CC(C)C)C(O)=O)=O)CO)=O)N)C1=CC=C(O)C=C1 |
Relative Density. | 1.293 g/cm3 (Predicted) |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | H2O: Soluble |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.